- Born October 1963
- Danish national
- Member of the Board of Directors since 2017
- Vice Chairman of the Board of Directors since 2018
- Member of the Audit and Nomination Committee
- Independent board member
Present managerial positions
Mr. Brandgaard serves as Executive Vice President of Biopharm and Legal Affairs at Novo Nordisk A/S, Denmark. Further, Mr. Brandgaard is Chairman of the Board of Directors of SimCorp A/S, Denmark and a member of the Novo Nordisk Haemophilia Foundation Council, Switzerland.
Experience from group management in a multinational pharmaceutical company, including responsibility for strategy development and implementation, information technology and finance. Financial and accounting experience.
Mr. Brandgaard holds an MSc in Economics and Auditing, as well as an MBA, both from the Copenhagen Business School, Denmark.